EVOLVE: Difference between revisions

Jump to navigation Jump to search
99 bytes added ,  21 August 2015
no edit summary
No edit summary
No edit summary
Line 153: Line 153:


==Funding==<!-- remove when cleared by an editor -->
==Funding==<!-- remove when cleared by an editor -->
* National Heart, Lung, and Blood Institute (NHLBI)
* Amgen (manufacturer of Cinacalcet) provided funding.
* AstraZeneca (Medication donation)
** Representatives of Amgen as nonvoting members were placed on the executive committee
* Pfizer (Medication donation, financial support)
** Amgen collected and analyzed trial data to a predefined statistical analysis plan
* Cordis (Angioguard device, financial support)
** Analyses were verified by independent statisticians
 
==Further Reading==
==Further Reading==
<references/>
<references/>
495

edits

Navigation menu